Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caplyta® in the Treatment of Social Anxiety Disorder: A Double-Blind Study

NCT07799493 is registered in ClinicalTrials.gov with Jason Careri as lead sponsor.

NCT NCT07799493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07799493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caplyta® in the Treatment of Social Anxiety Disorder: A Double-Blind Study
Lead sponsor
Jason Careri
Phase
Phase 4
Overall status
Recruiting
Start date
September 10, 2026
Completion date
May 28, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder (sad)